The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of institutional clinical trial enrollment volume on survival of patients with stage III non-small cell lung cancer treated with chemoradiation: A report of the Radiation Therapy Oncology Group (RTOG) 0617.
Bree Ruppert Eaton
No relevant relationships to disclose
Stephanie L. Pugh
No relevant relationships to disclose
Jeffrey D Bradley
No relevant relationships to disclose
Vivek Kavadi
No relevant relationships to disclose
Samir Narayan
No relevant relationships to disclose
Lucien Alexander Nedzi
No relevant relationships to disclose
Cliff Grant Robinson
No relevant relationships to disclose
Melvin Deutsch
No relevant relationships to disclose
Christoper D. Koprowski
No relevant relationships to disclose
Douglas W. Johnson
No relevant relationships to disclose
JoAnne Meng
No relevant relationships to disclose
Walter J. Curran
No relevant relationships to disclose